These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 720482)

  • 21. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
    Sibley DR; Creese I
    Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermodynamic analysis of antagonist and agonist interactions with dopamine receptors.
    Duarte EP; Oliveira CR; Carvalho AP
    Eur J Pharmacol; 1988 Mar; 147(2):227-39. PubMed ID: 2452751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H] spiroperidol binding to brain neurotransmitter receptors.
    Withy RM; Mayer RJ; Strange PG
    FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
    [No Abstract]   [Full Text] [Related]  

  • 25. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 27. Immuno-photoaffinity labeling of the D2-dopamine receptor.
    Kanety H; Fuchs S
    Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine receptors in the central nervous system.
    Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
    Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affinities of drugs for the agonist and antagonist states of the dopamine receptor.
    Riddall DR; Leavens WJ
    Eur J Pharmacol; 1978 Sep; 51(2):187-8. PubMed ID: 699984
    [No Abstract]   [Full Text] [Related]  

  • 30. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
    Varmuza S; Mishra RK
    Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and partial purification of a hydrophobic protein component associated with [3H]spiroperidol-binding activity.
    Boyan-Salyers BD; Clement-Cormier Y
    Biochim Biophys Acta; 1980 Feb; 617(2):274-81. PubMed ID: 7357020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
    Köhler C; Fuxe K; Ross SB
    Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 38. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptors in the Parkinsonian brain.
    Rinne UK; Lönnberg P; Koskinen V
    J Neural Transm; 1981; 51(1-2):97-106. PubMed ID: 6114985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.
    Fields JZ; Gordon JH
    Life Sci; 1982 Jan; 30(3):229-34. PubMed ID: 7200183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.